PI6 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Pieris Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 97.5 EUR

Market Cap: €9.6B

	Pieris Pharmaceuticals Inc F:PI6	US
K	Keppel Corporation Ltd XMUN:KEP1	SG
	Clear Channel Outdoor Holdings Inc F:C7C1	US
	Firstsource Solutions Ltd BSE:532809	IN
M	MarineMax Inc F:MLW	US
	Thungela Resources Ltd F:6UP	ZA

Profitability Summary

Pieris Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-1.339%

Negative 3Y Average Operating Margin

-282%

Declining Operating Margin

-270% > -1.339%

Negative Net Margin

-1.180%

Negative 3Y Average Net Margin

-255%

Declining Net Margin

-245% > -1.180%

Negative Free Cash Flow Margin

-2.070%

Negative 3Y Average Free Cash Flow Margin

-456%

Declining Free Cash Flow Margin

-291% > -2.070%

Negative ROE

-68%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-148%

Declining ROIC

-151% > -299%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.